Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Angewandte Chemie

• Publication date

  2002-08-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/1521-3773(20020816)41:16<2940::AID-ANIE2940>3.0.CO;2-MPMID 12203418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urotensin II evokes potent vasoconstriction in humans in vivo

  2002cited by this paper
• Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

  2002cited by this paper
• Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats

  2001cited by this paper
• Synergistic Effect of Urotensin II With Mildly Oxidized LDL on DNA Synthesis in Vascular Smooth Muscle Cells

  2001cited by this paper
• Depressor and regionally‐selective vasodilator effects of human and rat urotensin II in conscious rats

  2001cited by this paper
• Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

  2000cited by this paper
• Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads.

  2000cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates.

  1996cited by this paper
• A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia.

  1995cited by this paper
• Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors.

  1995cited by this paper
• Molecular modelling and design of analogues of the peptide hormone urotensin II.

  1990cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper

• Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators.

  2024cites this paper
• Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor

  2022cites this paper
• Urotensin receptor in GtoPdb v.2021.3

  2021cites this paper
• Urotensin receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Natural and synthetic peptides in the cardiovascular diseases: An update on diagnostic and therapeutic potentials.

  2019cites this paper
• Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides.

  2019cites this paper
• Effects of Urotensin II on Excitation-Contraction Coupling in Hypertrophic Heart Failure

  2018cites this paper
• Insight into the role of urotensin II‐related peptide tyrosine residue in UT activation

  2017cites this paper
• Long-scale molecular dynamics simulations of cyclic peptide hormones vasopressin, urotensin and analogues

  2017cites this paper
• Synthèse en phase solide de pyrrolo[3,2-e][1,4]diazépin-2-ones modulateurs du système urotensinergétique

  2017cites this paper
• Conformation and Dynamics of Human Urotensin II and Urotensin Related Peptide in Aqueous Solution

  2017cites this paper
• Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor.

  2017cites this paper
• Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.

  2016cites this paper
• Structure–Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position 9

  2016cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015influential citation
• NMR spectroscopy: a useful tool for drugs development and monitoring biological reactions

  2015cites this paper
• An investigation into the origin of the biased agonism associated with the urotensin II receptor activation

  2015cites this paper
• Comparative Distribution and In Vitro Activities of the Urotensin II-Related Peptides URP1 and URP2 in Zebrafish: Evidence for Their Colocalization in Spinal Cerebrospinal Fluid-Contacting Neurons

  2015cites this paper
• Urotensin‐II receptor is over‐expressed in colon cancer cell lines and in colon carcinoma in humans

  2014cites this paper
• Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.

  2014cites this paper
• Design of a truncated cardiotoxin-I analogue with potent insulinotropic activity.

  2014cites this paper
• Urantide Conformation and Interaction with the Urotensin‐II Receptor

  2014cites this paper
• Improving Pseudomonas alcaligenes lipase’s diastereopreference in hydrolysis of diastereomeric mixture of menthyl propionate by site-directed mutagenesis

  2014cites this paper
• New insight into the binding mode of peptides at urotensin‐II receptor by Trp‐constrained analogues of P5U and urantide

  2013cites this paper
• Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.

  2013cites this paper
• Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• The use of G-protein coupled receptor models in lead optimization.

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Urotensin-II receptor modulators as potential drugs.

  2010cites this paper
• Untersuchung der proteolytischen Prozessierung von humanen Urotensin-Peptiden

  2010influential citation
• Suche, Reinigung und Identifizierung eines Urotensin II metabolisierenden Enzyms

  2010cites this paper
• Urotensin II, from fish to human

  2010cites this paper
• Involvement of Novel Cardiac Peptides in Healthy and Ischemic Hearts

  2009influential citation
• Human urotensin-II receptor desensitisation

  2009cites this paper
• Structure–activity relationship study on Tyr9 of urotensin-II(4–11): Identification of a partial agonist of the UT receptor

  2009cites this paper
• New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.

  2009cites this paper
• Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.

  2009cites this paper
• Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.

  2009cites this paper
• Identification of new agonists of urotensin-II from a cyclic peptide library.

  2009cites this paper
• Generation of novel, potent urotensin-II receptor antagonists by alkylation-cyclization of isoindolinone C3-carbanions

  2009cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• Behavioral actions of urotensin-II.

  2008cites this paper
• Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas.

  2008cites this paper
• Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II.

  2008influential citation
• Synthèse de ligands du récepteur de l'Urotensine II et des récepteurs de la Mélatonine : composés à noyau pyrido[2,3-d]pyrimidine ou imidazo[1,2-a]pyridine

  2008influential citation
• Role of urotensin II in atherosclerotic cardiovascular diseases.

  2008cites this paper
• Structure-activity relationships of urotensin II and URP.

  2008cites this paper
• Structure–activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11)

  2008cites this paper
• [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes.

  2008cites this paper
• Three‐dimensional model of the human urotensin‐II receptor: Docking of human urotensin‐II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model

  2008cites this paper
• Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.

  2008cites this paper
• Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[(18)F]fluorobenzoate and application to (18)F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography.

  2008cites this paper
• Role of urotensin II and its receptor in health and disease

  2007cites this paper
• Urotensin‐II Induces Ear Flushing in Rats

  2007cites this paper
• RESEARCH PAPER Urotensin-II Induces Ear Flushing in Rats

  2007cites this paper
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cites this paper
• Definition of New Pharmacophores for Nonpeptide Antagonists of Human Urotensin-II. Comparison with the 3D-structure of Human Urotensin-II and URP

  2007cites this paper
• Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessment.

  2007cites this paper
• Design and synthesis of potent cystine-free cyclic hexapeptide agonists at the human urotensin receptor.

  2006cites this paper
• Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide.

  2006cites this paper
• Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.

  2006cites this paper
• Biochemical and functional characterization of high‐affinity urotensin II receptors in rat cortical astrocytes

  2006cites this paper
• Urotensin II and Urotensin II–Related Peptide

  2006cites this paper
• Localization of the urotensin II receptor in the rat central nervous system

  2006cites this paper
• Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts.

  2006cites this paper
• Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists.

  2005cites this paper
• Structure–activity relationship study on human urotensin II

  2005cites this paper
• Development and pharmacological characterization of "caged" urotensin II analogs.

  2005cites this paper
• Isochromanone-based urotensin-II receptor agonists.

  2005cites this paper
• Metallacyclopeptides: artificial analogues of naturally occurring peptides.

  2005cites this paper
• Behavioral effects of urotensin-II centrally administered in mice

  2005cites this paper
• Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors.

  2005cites this paper
• Urotensin-II receptor ligands. From agonist to antagonist activity.

  2005cites this paper
• Urotensin II: Its Function in Health and Its Role in Disease

  2005cites this paper
• Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord.

  2005cites this paper
• Guide to Receptors and Channels, 1st Edition

  2004cites this paper
• Urotensin II: the old kid in town.

  2004cites this paper
• Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas.

  2004cites this paper
• From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function.

  2004cites this paper
• Preparation of tripeptide-bridged dicatechol ligands and their macrocyclic molybdenum(VI) complexes: fixation of the RGD sequence and the WKY sequence of urotensin ii in a cyclic conformation.

  2004cites this paper
• Urotensin‐II receptor peptide agonists

  2004influential citation
• Identification and pharmacological characterization of native, functional human urotensin‐II receptors in rhabdomyosarcoma cell lines

  2004cites this paper
• Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.

  2004cites this paper
• Emerging roles of urotensin-II in cardiovascular disease.

  2004cites this paper
• Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord

  2004cites this paper
• Chapter 11. Urotensin-II receptor modulators

  2003cites this paper
• The neuromedin B receptor antagonist, BIM‐23127, is a potent antagonist at human and rat urotensin‐II receptors

  2003cites this paper
• Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

  2003cites this paper
• Functional and Binding Characterizations of Urotensin II-Related Peptides in Human and Rat Urotensin II-Receptor Assay

  2003cites this paper